# Zentynel Frontier Investments

> Zentynel Frontier Investments is a VC fund backing Health Care. See 17 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Santiago, Chile
- Total investments: 17
- Last investment: Jan 2026
- Lead investor: 59%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/zentynel-frontier-investments
- Website: https://zentynel.com

Zentynel Frontier Investments is a VC fund in Santiago focused on Health Care and Biotechnology. Zentynel Frontier is a investment firm.

## Contacts

5 contacts available for Zentynel Frontier Investments. Shizune tracks 1 team members at Zentynel Frontier Investments. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/zentynel-frontier-investments?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $400k–$6M |
| Series A | $500k–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 41% |
| Biotechnology | 7 | 41% |
| Medical | 4 | 24% |
| Artificial Intelligence | 3 | 18% |
| Fitness | 2 | 12% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 35% |
| Series A | 5 | 29% |
| Venture - Series Unknown | 2 | 12% |
| Angel | 1 | 6% |
| Pre-Seed | 1 | 6% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 5 | 29% |
| Uruguay | 2 | 12% |
| Argentina | 2 | 12% |
| Brazil | 1 | 6% |
| Mexico | 1 | 6% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Roberto Loehnert | General Partner | 1 | https://shizune.co/investors/profile/roberto-loehnert |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BIOMAKERS | BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment. | $8M | Series A | Jan 12, 2026 |  |
| Axenya | Axenya leverages the power of data to deliver personalized health, greater control, and cost savings. They design solutions for managing a company's corporate health. | $12M | Series A | Aug 25, 2025 |  |
| Asclepii | Asclepii is a medical device company that specializes in providing healthcare professionals with advanced tools and solutions in the field of regenerative medicine. The company develops innovative products that aim to improve the body's natural healing processes by promoting tissue regeneration and reducing recovery times. Its solutions aredesigned to address various types of wounds, including chronic, acute, and surgical wounds, offering both practical and effective care options. With a commitment to advancing healthcare through technology and research, Asclepii works closely with medical experts to deliver tailored devices that enhance patient outcomes. The company’s focus remains on improving wound care practices, offering healthcare providers effective regenerative medicine tools to aid in healing and tissue repair in clinical settings. | $500K | Seed | Mar 21, 2025 |  |
| Axenya | Axenya leverages the power of data to deliver personalized health, greater control, and cost savings. They design solutions for managing a company's corporate health. |  |  | Nov 25, 2024 |  |
| Fecundis | Nuevos medios de cultivo para capacitación de espermatozoides | $2.6M | Seed | Oct 08, 2024 |  |
| Xeptiva Therapeutics | Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthmain cats. Xeptiva's goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases. | $2.5M | Seed | Sep 23, 2024 |  |
| BIOMAKERS | BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment. | $5.9M | Venture - Series Unknown | Jun 06, 2024 |  |
| MultiplAI Health | MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superb biomarker to detect diseases earlier. Our test can be used in continuoustesting both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods. | $2.7M | Seed | Mar 02, 2023 |  |
| Samay | Respira Labs is developing the first wearable device to measure “trapped air,” an early marker of Chronic Obstructive Pulmonary Disease (COPD). No reliable and validated methods currently exist to detect COPD exacerbations in time for early intervention and prevention. By leveraging the power of non-invasive acoustic sensors, audio signalprocessing, machine learning and Acoustic Resonance Index Analysis (ARIA), our device will fundamentally revolutionize COPD management by predicting and preventing attacks at the patient’s home, significantly improving health outcomes and patient quality of life while dramatically lowering health care costs. | $1.5M | Pre-Seed | Dec 21, 2022 |  |
| Harmony Baby Nutrition | Harmony is a biotechnology startup that creates human breast milk protein-based infant nutrition designed to help human babies thrive. It is the world’s first dairy-free, allergen-free and environmentally friendly infant nutrition. Harmony Baby Nutrition was established in 2018 and is based in Boston, MA. | $6M | Seed | Nov 01, 2022 |  |

10 of 17 investments shown.

## Co-investors
- [Canary](https://shizune.co/investors/profile/canary-5) — VC Fund, 2 deals together
- [Fen Ventures](https://shizune.co/investors/profile/fen-ventures) — VC Fund, 2 deals together
- [ImpactAssets](https://shizune.co/investors/profile/impactassets) — VC Fund, 2 deals together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 2 deals together
- [Acumen LatAm Impact Ventures](https://shizune.co/investors/profile/acumen-latam-capital-partners) — VC Fund, 1 deal together
- [Amplifica Capital](https://shizune.co/investors/profile/amplifica-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Newtopia VC](https://shizune.co/investors/profile/newtopia-vc) — VC Fund
- [NXTP Ventures](https://shizune.co/investors/profile/nxtp-ventures) — VC Fund
- [Alaya Capital](https://shizune.co/investors/profile/alaya-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in LATAM](https://shizune.co/investors/biotechnology-investors-latam)
- [Biotechnology VC Funds in LATAM](https://shizune.co/investors/biotechnology-vc-funds-latam)
- [Biotech VC Funds in LATAM](https://shizune.co/investors/biotech-vc-funds-latam)
- [Medical VC Funds in LATAM](https://shizune.co/investors/medical-vc-funds-latam)
- [All Investors in Uruguay](https://shizune.co/investors/investors-uruguay)
- [All VC Funds in Uruguay](https://shizune.co/investors/vc-funds-uruguay)

## FAQ

### What does Zentynel Frontier Investments invest in?

Zentynel Frontier Investments invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Zentynel Frontier Investments's check size?

Zentynel Frontier Investments typically joins rounds of $400k–$6M at Seed and $500k–$17M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Zentynel Frontier Investments participates in.

### How do I contact Zentynel Frontier Investments?

Public channels for Zentynel Frontier Investments include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Zentynel Frontier Investments?

The team at Zentynel Frontier Investments includes Roberto Loehnert (General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co